Literaturverzeichnis
Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM, for the Women's Health Initiative Investigators (2003).
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 290: 1739-1748
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J,
Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712
Cauley JA, Black DM, Barrett-Connor E, Harris F, Shields K, Applegate W,
Cummings SR (2001). Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med 110: 442-450
Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, for the WHI Investigators (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized Trial. JAMA 289: 3243-3253
Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, for the Women's Health Initiative Investigators (2004). Estrogen plus
progestin and colorectal cancer in postmenopausal women. N Engl J Med: 991-1004
Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC (2005). Effect of estrogen therapy on gallbladder disease. JAMA 293: 330- 339
Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR, for the Women's Health Initiative Investigators (2004). Estrogen plus progestin and risk of venous thrombosis. JAMA 292: 1573-1580
Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J; Women's Health Initiative Memory Study (2004). Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291: 2959-2968
Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T, for the HERS Research Group (2001). Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97: 116-120
Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E (2002). Effect of postmenopausal hormone therapy on cognitive function: The Heart and
Estrogen/progestin Replacement Study. Am J Med 113: 543-548
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG, for the Women's Health Initiative Investigators (2003). Effects of estrogen plus progestin on health- related quality of life. NEJM 348: 1839-1854
Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallance RB, McNeeley SG (2005). Effects of estrogen with and without progestin on urinary incontinence. JAMA 293: 935-948
Hogervorst E, Yaffe K, Richards M, Huppert F (2003). Hormone replacement therapy to maintain cognitive function in women with dementia (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group (1998).
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613
Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA,
Barrett-Connor E (2003). Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138: 1-9
Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C (2002). Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288: 334-341
LeBlanc ES, Janowsky J, Chan BK, Nelson HD (2001). Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285: 1489-1499
MacLennan A, Lester S, Moore V (2003). Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review). In: The Cochrane Library, Issue 4, 2003.
Chichester, UK: John Wiley & Sons, Ltd
Manson JE, Martin KA (2001). Postmenopausal hormone-replacement therapy. N Engl J Med 345: 34-40
Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV (2004). Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47: 1175-1187
Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet 362: 419-427
Mühlhauser I, Kimmerle R, Berger M (1995). Langzeittherapie mit Sexualhormonen zur Krankheitsverhütung und Lebensverlängerung in der Postmenopause. Offene
Fragen unter besonderer Berücksichtigung des Diabetes mellitus. arznei-telegramm 4: 37-44
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 283: 1007-1015
Nevitt MC, Felson DT, Williams EN, Grady D (2001). The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 44: 811-818
Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D, for the WHIMS Investigators (2003). Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 289: 2663-2672
Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB (2001a). Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 103: 638-642
Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group (2001b). Effect of estrogen plus progestin on risk for bilary tract surgery in
postmenopausal women with coronary artery disease. Ann Intern Med 135: 493-501
Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291: 2947-2958
Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, for the WHIMS Investigators (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289: 2651-2662
Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI (2001). A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345: 1243- 1249
Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E,
Laowattana S, Mysiw WJ, for the WHI Investigators (2003). Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: A randomized trial. JAMA 289: 2673-2684
Writing Group for the Women's Health Initiative Investigators (WHI) (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:
321-333
